anti il6 af 206 na antibodies (R&D Systems)
Structured Review
Anti Il6 Af 206 Na Antibodies, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 77 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il6+antibody/Human+IL-6+Antibody/pm41997110-259-36-40
Average 93 stars, based on 77 article reviews
Images
Related Articles
Membrane:Article Title: Sensitization of EGFR Wild-Type Non-Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib. Article Snippet: They were grown and treated by the indicated drugs in 10% fetal bovine serum-containing medium (RPMI 1640, Gibco, ThermoFischer Scientific) unless otherwise stated. .. The references of the antibodies used were following: membrane EGFR, Santa Cruz #sc-120; membrane Her2, Santa Cruz #sc-23864; membrane Her3, Santa Cruz #sc-71068; phospho-EGFR (Y1068), Cell Signaling Technology #3777; phospho-AKT (S473), Cell Signaling Technology #9271; phospho-ERK1/2 (T202/Y204), Cell Signaling Technology #9101; total EGFR, Cell Signaling Technology #4267; GRB2, BD Biosciences #610112; pTyr100, Cell Signaling Technology #9411; blocking EGFR antibody (225), Invitrogen #MA512880; blocking Blocking Assay:Article Title: Sensitization of EGFR Wild-Type Non-Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib. Article Snippet: They were grown and treated by the indicated drugs in 10% fetal bovine serum-containing medium (RPMI 1640, Gibco, ThermoFischer Scientific) unless otherwise stated. .. The references of the antibodies used were following: membrane EGFR, Santa Cruz #sc-120; membrane Her2, Santa Cruz #sc-23864; membrane Her3, Santa Cruz #sc-71068; phospho-EGFR (Y1068), Cell Signaling Technology #3777; phospho-AKT (S473), Cell Signaling Technology #9271; phospho-ERK1/2 (T202/Y204), Cell Signaling Technology #9101; total EGFR, Cell Signaling Technology #4267; GRB2, BD Biosciences #610112; pTyr100, Cell Signaling Technology #9411; blocking EGFR antibody (225), Invitrogen #MA512880; blocking Control:Article Title: Sensitization of EGFR Wild-Type Non-Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib. Article Snippet: They were grown and treated by the indicated drugs in 10% fetal bovine serum-containing medium (RPMI 1640, Gibco, ThermoFischer Scientific) unless otherwise stated. .. The references of the antibodies used were following: membrane EGFR, Santa Cruz #sc-120; membrane Her2, Santa Cruz #sc-23864; membrane Her3, Santa Cruz #sc-71068; phospho-EGFR (Y1068), Cell Signaling Technology #3777; phospho-AKT (S473), Cell Signaling Technology #9271; phospho-ERK1/2 (T202/Y204), Cell Signaling Technology #9101; total EGFR, Cell Signaling Technology #4267; GRB2, BD Biosciences #610112; pTyr100, Cell Signaling Technology #9411; blocking EGFR antibody (225), Invitrogen #MA512880; blocking Article Title: IFIT2‐depleted metastatic oral squamous cell carcinoma cells induce muscle atrophy and cancer cachexia in mice Article Snippet: The DM for C2C12 cells was high‐glucose DMEM with 2% horse serum (GE Healthcare, Chicago, Illinois, USA). .. After 4 days in differentiation, cells were then treated with DM (as a control), 50% shIFIT2 conditioned medium (CM) in DM with or without neutralizing Article Title: IFIT2-depleted metastatic oral squamous cell carcinoma cells induce muscle atrophy and cancer cachexia in mice. Article Snippet: The DM for C2C12 cells was high-glucose DMEM with 2% horse serum (GE Healthcare, Chicago, Illinois, USA). .. After 4 days in differentiation, cells were then treated with DM (as a control), 50% shIFIT2 conditioned medium (CM) in DM with or without neutralizing Negative Control:Article Title: Tumor exposed-lymphatic endothelial cells promote primary tumor growth via IL6 Article Snippet: .. Human neutralizing anti - Suspension:Article Title: Tumor exposed-lymphatic endothelial cells promote primary tumor growth via IL6 Article Snippet: .. Human neutralizing anti - Neutralization:Article Title: Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line Article Snippet: Adherent MCF-7 cells were grown to 20% confluence in complete medium, washed twice in PBS 1× before the addition of 50 ng/ml of human recombinant IL8 (PHC0084, Invitrogen), IL6 (PHC0065, Invitrogen) or the mixture (IL6 + IL8) in 0,5% FBS MEMα medium. .. For neutralization experiments, MCF-7 cells were incubated with SCM containing 1 μg/ml of human CXCL8/IL-8 antibody (AF-208-NA, R&D SYSTEMS), Incubation:Article Title: Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line Article Snippet: Adherent MCF-7 cells were grown to 20% confluence in complete medium, washed twice in PBS 1× before the addition of 50 ng/ml of human recombinant IL8 (PHC0084, Invitrogen), IL6 (PHC0065, Invitrogen) or the mixture (IL6 + IL8) in 0,5% FBS MEMα medium. .. For neutralization experiments, MCF-7 cells were incubated with SCM containing 1 μg/ml of human CXCL8/IL-8 antibody (AF-208-NA, R&D SYSTEMS), other:Article Title: IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer Article Snippet: To evaluate the effects of IL6 on cell viability, treatment conditions included supernatants from TAF cultures (high IL6 conditions) with or without neutralizing |
